Entia Biosciences
14991 SW Tualatin-Sherwood Rd #206
Sherwood
Oregon
97140
United States
Tel: 1-503-334-3590
Fax: 1-503-610-1876
Website: http://www.entiabio.com/
13 articles about Entia Biosciences
-
Entia Biosciences Receives Notification Of The Grant Of European Patent It Has Exclusively Licensed For Identifying The Ergothioneine Transporter And Its Therapeutic Uses
11/3/2016
-
Entia Biosciences To Present Results Of Chronic Kidney Disease Medical Food Clinical Study At American Society of Nephrology/Kidney Week 2016 Annual Meeting
10/7/2016
-
Preliminary Clinical Results For Entia Biosciences's New, Proprietary Ergod2 Medical Food Show An Average Increase In Kidney Filtration Rate Of Approximately 10% For Over 75% Of Test Subjects, After Only Three Months
9/26/2016
-
Entia Biosciences Begins Clinical Study Of Proprietary Ergod2 Medical Food Product To Demonstrate Improved Health For The More Than 25 Million Chronic Kidney Disease Sufferers In The U.S.
12/21/2015
-
Entia Biosciences Secures The Michael J. Fox Foundation Grant
7/15/2014
-
Entia Biosciences Director of Marketing for Medical Foods and Consumer Products
5/16/2013
-
Entia Biosciences Receives Notices of Allowance for Its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
4/2/2013
-
Entia Biosciences Files Nutrigenomics Patent for Hair, Skin, and Nails
1/7/2013
-
Entia Biosciences Receives Canadian Patent Notice of Allowance for Use of Ergothioneine and Its Genetic Transporter
12/17/2012
-
Entia Biosciences Receives Patent for Use of Ergothioneine in Foods and Beverages
6/14/2012
-
Entia Biosciences Begins Multi-site Clinical Trial of Medical Food for Treatment of Diabetes and Anemia
6/7/2012
-
Entia Biosciences Launches Medical Food for Treatment of Rheumatoid Arthritis
5/2/2012
-
Entia Biosciences Developing ErgoD2(TM) Line of Medical Foods
2/27/2012